Zhu, J., Wang, P., Li, F., Lu, J., Shehu, A. I., Xie, W., . . . Ma, X. (2018). CYP1A1 and 1B1-mediated metabolic pathways of dolutegravir, an HIV-1 integrase inhibitor. Biochem Pharmacol.

Zhu, Junjie, Pengcheng Wang, Feng Li, Jie Lu, Amina I. Shehu, Wen Xie, Deborah McMahon, and Xiaochao Ma. "CYP1A1 and 1B1-mediated Metabolic Pathways of Dolutegravir, an HIV-1 Integrase Inhibitor." Biochem Pharmacol 2018.

Zhu, Junjie, et al. "CYP1A1 and 1B1-mediated Metabolic Pathways of Dolutegravir, an HIV-1 Integrase Inhibitor." Biochem Pharmacol 2018.